• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Antidepressants associated with decreased fertility

byDenise PongandLeah Hawkins Bressler, MD, MPH
January 31, 2016
in Obstetrics, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Antidepressant use during a given menstrual cycle was associated with decreased fecundability during that cycle.

2. History of anxiety or depression was not independently associated with decreased fertility.

Evidence Rating Level: 2 (Good)

Study Rundown: Antidepressants are one of the most frequently prescribed classes of drugs in the United States. Overall, the benefits of treating major depression in pregnancy greatly outweigh the risks. Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used antidepressants in pregnancy and are associated with a low risk of teratogenicity, with the exception of paroxetine. While the effects of antidepressants in pregnancy has been studied, much less is known about the impact of antidepressants on fertility. Animal and human models suggest that antidepressants increase the levels of allopregnanolone, a neuroactive substance that may alter normal hypothalamic-pituitary axis function. Prior studies demonstrated that allopregnanolone was associated with reduced levels of FSH and LH and decreased likelihood of ovulation. In the present work, authors evaluated their hypothesis that antidepressant use has a negative impact on fecundability. Their secondary analysis supported this hypothesis and found that antidepressant use during a given menstrual cycle was associated with reduced likelihood of conception during that cycle.

Strengths of the study included prospective design, inclusion of known confounders, and detailed daily data collection. However, caution is warranted when interpreting findings. Because depression itself can be associated with decreased libido or isolating behaviors, a comparison group of healthy woman may bias results away from the null. The most well-designed studies to responsibly address the impact of medical treatment of depression would compare outcomes in women with depression who are currently on medication to women with depression not currently on medication. Additional limitations were poor generalizability to other populations and lack of evaluation of the indication for and dose of antidepressant medications. Further prospective studies evaluating the impact of depression, medication and specifically assessing dose-response relationships are needed to guide recommendations for antidepressant use in women attempting pregnancy.

Click to read the study in AJOG

Relevant Reading: Allopregnanolone, a GABAA receptor agonist, decreases gonadotropin levels in women: a preliminary study

RELATED REPORTS

Increased infertility rates found amongst female physicians compared to general population

Association between CYP metabolizer phenotypes and SSRI induced weight gain

No difference in live birth rates between intracytoplasmic sperm injection and conventional in-vitro fertilization for couples with non-male factor infertility

In-Depth [prospective cohort]: This secondary analysis evaluated the likelihood of conception among women aged 30 to 44 years who used antidepressant medications (n = 92) and those who did not (n = 865). The primary outcome of interest was a positive pregnancy test.

The rate of antidepressant use at any point during the study period was 9.6%. Baseline use of antidepressants was not associated with differences in fecundability overall. However, after adjustment for a history of anxiety and depression, antidepressant use during a given menstrual cycle was associated with decreased fecundability during that cycle (FR 0.66, CI 0.45-0.97).

Image: CC/Wiki/tom varco

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antidepressantsfertility
Previous Post

Smoking associated with increased mortality in breast cancer patients

Next Post

Hands and knees position ineffective for fetal rotation, improves comfort

RelatedReports

Maternal vaccination during pregnancy not associated with infant hospitalization, mortality
Chronic Disease

Increased infertility rates found amongst female physicians compared to general population

November 10, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Association between CYP metabolizer phenotypes and SSRI induced weight gain

August 4, 2022
Mental retardation associated with IVF treatment
Chronic Disease

No difference in live birth rates between intracytoplasmic sperm injection and conventional in-vitro fertilization for couples with non-male factor infertility

May 6, 2021
#VisualAbstract: Ofatumumab vs. teriflunomide for multiple sclerosis
StudyGraphics

#VisualAbstract: Association between antidepressants during early pregnancy and risk of birth defects

August 20, 2020
Next Post
Late gestation antidepressant use linked to postpartum hemorrhage

Hands and knees position ineffective for fetal rotation, improves comfort

Fruit consumption among US youth differs by age, race

Increased fiber in young adulthood may lower breast cancer risk

AAP releases 2016 recommendations for childhood and adolescent immunizations

AAP releases 2016 recommendations for childhood and adolescent immunizations

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options